Pharm'Up
A recent study from Mass General Brigham investigators has revealed that an investigational drug, larazotide, which was...
Pharm'Up
An E-platform for Pharma Learners
August marks National Immunization Awareness Month (NIAM), a crucial time for pharmacists to step into a leading...
In a significant development for patients with a devastating and rare brain cancer, the U.S. Food and...
A recent study published in Scientific Reports is challenging long-held assumptions about the effects of caffeine on...
The One Big Beautiful Bill Act (OBBBA), signed by President Donald J. Trump in July 2025, contains...
The Trump administration’s new tax law, the “One Big Beautiful Bill Act” (OBBB), has stirred significant debate...
A new review and meta-analysis published in Frontiers in Pharmacology indicates that inclisiran (Leqvio), a novel small...
The Department of Health and Human Services (HHS), under the direction of Secretary Robert F. Kennedy Jr.,...
The FDA has granted a significant expanded approval for fremanezumab-vfrm (Ajovy), a calcitonin gene-related peptide (CGRP) antagonist...
The FDA has officially expanded the approval of the intravenous (IV) formulation of tocilizumab-anoh (Avtozma; Celltrion Inc),...
